Skip to NavigationSkip to content

News

0
lilly
Lilly and Takeda products now available in the US and Japan
0
Eisai image
High dose of existing offering could be used to treat debilitating condition in Japan
0
Viberzi and Xifaxan jump US regulator hurdles to treat irritable bowel syndrome
0
NICE image
Healthcare watchdog launches ‘comprehensive consultancy’ in response to industry pleas for help 

Features

cameron

The BIA, ABPI, MedCity and pharma insiders weigh in on what the industry’s relationship with the new Conservative government might look like